SAFETY OF AMIODARONE USAGE IN PATIENTS WITH WOLFF-PARKINSON-WHITE SYNDROME AND ATRIAL FIBRILLATION
Amiodarone is one of the basic antiarrhytmic drugs for atrial fibrillation treatment. However application of amiodarone in patients with atrial fibrillation and Wolff-Parkinson-White syndrome can induce ventricular fibrillation. Amiodarone usage in these patients should be accompanied by readiness f...
Saved in:
Main Authors: | D. A. Kuzhel (Author), G. V. Matyushin (Author), E. A. Savchenko (Author) |
---|---|
Format: | Book |
Published: |
Столичная издательская компания,
2016-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A rare manifestation of atrial fibrillation in the presence of Wolff-Parkinson-White syndrome: tachycardia-induced cardiomyopathy
by: Aleks Değirmencioğu, et al.
Published: (2014) -
POLYMORPHISMS OF ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE AS PREDICTORS OF WOLFF-PARKINSON-WHITE SYNDROME
by: G. V. Matyushin, et al.
Published: (2017) -
Wolff-Parkinson-White Syndrome: Electrocardiogram
by: Brianna Miner, et al.
Published: (2016) -
Sindrom Wolff Parkinson White
by: Sri Endah Rahayuningsih
Published: (2016) -
Syndrome and Phenomenon of Wolff - Parkinson - White in Children (Literature Review)
by: N.V. Nagornaya, et al.
Published: (2013)